Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - NOVELION THERAPEUTICS INC.c24128exv99w1.htm
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 3, 2011
QLT Inc.
(Exact name of registrant as specified in its charter)
         
British Columbia, Canada   000-17082   N/A
         
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer Identification No.)
     
887 Great Northern Way,
Suite 101, Vancouver, B.C. Canada,
   
V5T 4T5
     
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code: (604) 707-7000
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 


 

Item 2.02  
Results of Operations and Financial Condition.
On November 3, 2011, QLT Inc. reported its financial results for the third quarter ended September 30, 2011, updated certain financial guidance and provided an update on its pipeline. The full text of the press release announcing such results is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Such information shall not be deemed “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and is not incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
Item 9.01.  
Financial Statements and Exhibits.
(d) Exhibits
         
Exhibit No.   Description
       
 
  99.1    
Press Release of QLT Inc. dated November 3, 2011.

 

 


 

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  QLT INC.
 
 
Date: November 3, 2011  By:   /s/ Cameron Nelson    
    Name:   Cameron Nelson   
    Title:   Senior Vice President, Finance and
Chief Financial Officer 
 

 

 


 

Exhibit Index
         
Exhibit No.   Description
       
 
  99.1    
Press Release of QLT Inc. dated November 3, 2011.